Jianwei Zhang

13PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 30, 2026
Mitochondrial fitness in circulating T cells predicts neoadjuvant therapy response in locally advanced colorectal cancer.

|May 22, 2026
PTEN deficiency impairs MHC-I-mediated tumour immunity via NRF2-dependent autophagy in microsatellite stable colorectal cancer.

|Sep 24, 2025
Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study.

Chenchen Li, Peicong Cai, Hengda Zeng

|Jul 18, 2025
Immune checkpoint inhibitors improve the efficacy of neoadjuvant chemotherapy in advanced gastric cancer: a retrospective cohort study.

Yonghe Chen, Yi Lin, Yingying Xu

|Dec 13, 2024
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years.

Jianwei Zhang, Pan Chi, Lishuo Shi

|Apr 02, 2024
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.

Huabin Hu, Jianwei Zhang, Yunfeng Li

Pageof 3

Frequent Collaborators

8 joint publications

Yanhong Deng

4 joint publications

Huabin Hu

4 joint publications

Lishuo Shi

3 joint publications

Zehua Wu